The antimalarial primaquine is among the agents that may trigger hemolysis among G6PD-deficient people, and primaquine-sensitive erythrocytes were crucial in demonstrating the pathophysiology of the G6PD deficiencies.2 This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.